Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA

Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL‐10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL‐10–/– animals. Unlike IL‐10–/– m...

Full description

Saved in:
Bibliographic Details
Published inEuropean Journal of Immunology Vol. 36; no. 12; pp. 3248 - 3255
Main Authors Siewe, Lisa, Bollati–Fogolin, Mariela, Wickenhauser, Claudia, Krieg, Thomas, Müller, Werner, Roers, Axel
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag 01.12.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL‐10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL‐10–/– animals. Unlike IL‐10–/– mice, however, T cell‐specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL‐10 from non‐T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell‐specific IL‐10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL‐10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil‐specific IL‐10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL‐10–/– mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil‐specific IL‐10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL‐10 from different cellular sources.
AbstractList Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10(-/-) animals. Unlike IL-10(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources.Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10(-/-) animals. Unlike IL-10(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources.
Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL‐10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL‐10 –/– animals. Unlike IL‐10 –/– mice, however, T cell‐specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL‐10 from non‐T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell‐specific IL‐10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL‐10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil‐specific IL‐10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL‐10 –/– mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil‐specific IL‐10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL‐10 from different cellular sources.
Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10(-/-) animals. Unlike IL-10(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources.
Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10 super(-/-) animals. Unlike IL-10 super(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10 super(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources.
Author Roers, Axel
Krieg, Thomas
Müller, Werner
Bollati–Fogolin, Mariela
Wickenhauser, Claudia
Siewe, Lisa
Author_xml – sequence: 1
  givenname: Lisa
  surname: Siewe
  fullname: Siewe, Lisa
– sequence: 2
  givenname: Mariela
  surname: Bollati–Fogolin
  fullname: Bollati–Fogolin, Mariela
– sequence: 3
  givenname: Claudia
  surname: Wickenhauser
  fullname: Wickenhauser, Claudia
– sequence: 4
  givenname: Thomas
  surname: Krieg
  fullname: Krieg, Thomas
– sequence: 5
  givenname: Werner
  surname: Müller
  fullname: Müller, Werner
– sequence: 6
  givenname: Axel
  surname: Roers
  fullname: Roers, Axel
  email: axel.roers@uni‐koeln.de
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17111348$$D View this record in MEDLINE/PubMed
BookMark eNqFkUFv1DAUhC3Uim5bjlyRT9zSPseOEx-rpZRFq4JEOVtO8tK6JHawnaK9cePKb-SXkLJtQUjQ05PefDOHmX2y47xDQp4zOGIA-TFe26McQHIJLH9CFqzIWSaYYDtkAcBElqsK9sh-jNcAoGShnpI9VjLGuKgW5NvKJQw9Tp-s-_H1OwPaYrA32NIu-IEOpgl-vDKXGKlx7bEP1OGUbn-2jzTg5dSbNIvpCql1XW-GwSQfNrMUR-8i0uTp-v0HWk-JOp9-gX9qy_GMvjo_OSS7nekjPru7B-Tj69OL5Zts_e5stTxZZw0vIc8aFFJ10tSNQZOLmreNkEVRtaZAUdWs4NxAW5Q5F9BAVdVKltiBxI7zrmgUPyAvt7lj8J8njEkPNjbY98ahn6KWVT5Xw8SjIFNSqVLwGXxxB071gK0egx1M2Oj7jmeAb4G5yhgDdrqxySTrXQrG9pqBvl1Sz0vqhyVnV_aX6yH4H3y55b_YHjf_h_Xp29Vv50_8arF8
CitedBy_id crossref_primary_10_4049_jimmunol_1701340
crossref_primary_10_4049_jimmunol_1701582
crossref_primary_10_1016_j_intimp_2016_07_033
crossref_primary_10_1128_IAI_00825_07
crossref_primary_10_1371_journal_pone_0213813
crossref_primary_10_1038_srep42851
crossref_primary_10_1128_IAI_01148_13
crossref_primary_10_3390_jcm8111981
crossref_primary_10_4049_jimmunol_1102755
crossref_primary_10_1681_ASN_2012070684
crossref_primary_10_1002_eji_201041307
crossref_primary_10_1016_j_immuni_2016_05_005
crossref_primary_10_1016_j_immuni_2014_03_012
crossref_primary_10_1016_j_febslet_2014_01_015
crossref_primary_10_1155_2014_481750
crossref_primary_10_1111_imr_12208
crossref_primary_10_3389_fimmu_2019_02402
crossref_primary_10_1111_vco_12529
crossref_primary_10_1016_j_thromres_2024_109236
crossref_primary_10_1016_j_clim_2012_02_005
crossref_primary_10_1016_j_ejphar_2011_09_166
crossref_primary_10_1073_pnas_1219852110
crossref_primary_10_1016_j_cytogfr_2010_09_002
crossref_primary_10_1097_SHK_0b013e318225ad7e
crossref_primary_10_2217_dmt_15_44
crossref_primary_10_1371_journal_pone_0137366
crossref_primary_10_1016_j_neuropharm_2024_109890
crossref_primary_10_3389_fimmu_2020_01794
crossref_primary_10_1038_nri2711
crossref_primary_10_1042_BSR20201859
crossref_primary_10_4049_jimmunol_1201126
crossref_primary_10_1074_jbc_M110_207738
crossref_primary_10_1371_journal_ppat_1004049
crossref_primary_10_1002_eji_200939592
crossref_primary_10_1371_journal_ppat_1003476
crossref_primary_10_1016_j_jaci_2011_08_032
crossref_primary_10_1016_j_livsci_2011_12_006
crossref_primary_10_1126_sciadv_adu4369
crossref_primary_10_4049_jimmunol_0900788
crossref_primary_10_1177_1933719108325757
crossref_primary_10_1016_j_jneuroim_2016_04_010
crossref_primary_10_4049_jimmunol_1601340
crossref_primary_10_1371_journal_pone_0154621
crossref_primary_10_1016_j_clim_2011_08_012
crossref_primary_10_1158_2326_6066_CIR_14_0169
crossref_primary_10_1038_icb_2010_40
crossref_primary_10_4049_jimmunol_181_9_5956
crossref_primary_10_1007_s12026_009_8150_5
crossref_primary_10_1038_ncomms8055
crossref_primary_10_1074_jbc_RA117_000158
crossref_primary_10_1016_j_febslet_2007_08_015
crossref_primary_10_1128_iai_00360_23
crossref_primary_10_1007_s12032_017_1055_6
crossref_primary_10_1371_journal_ppat_1003735
crossref_primary_10_1002_eji_200838184
crossref_primary_10_1073_pnas_2018278118
crossref_primary_10_1155_2011_383962
crossref_primary_10_3390_ijms20236008
crossref_primary_10_4049_jimmunol_1800070
crossref_primary_10_3389_fimmu_2018_02625
crossref_primary_10_1016_j_chom_2013_05_013
crossref_primary_10_1016_j_celrep_2023_112171
crossref_primary_10_1074_jbc_M117_805424
crossref_primary_10_1371_journal_pone_0169531
crossref_primary_10_1111_j_1365_3083_2012_02695_x
crossref_primary_10_1002_ibd_21587
crossref_primary_10_1155_2018_4315140
crossref_primary_10_1016_j_bbrc_2008_02_043
crossref_primary_10_4049_jimmunol_1103421
crossref_primary_10_1038_ni_1640
crossref_primary_10_1016_j_imbio_2015_06_019
crossref_primary_10_1073_pnas_0904955106
crossref_primary_10_1016_j_immuni_2008_03_003
crossref_primary_10_1016_j_micinf_2011_12_012
crossref_primary_10_1007_s00535_015_1084_x
crossref_primary_10_1016_j_intimp_2022_108920
crossref_primary_10_1016_j_cellimm_2007_01_008
crossref_primary_10_1111_pim_12297
crossref_primary_10_1016_j_biomaterials_2017_06_013
crossref_primary_10_1016_j_coi_2007_05_007
crossref_primary_10_3923_ijp_2014_389_397
crossref_primary_10_1016_j_intimp_2017_02_004
crossref_primary_10_1016_j_theriogenology_2014_04_022
crossref_primary_10_4049_jimmunol_0900185
crossref_primary_10_1089_jop_2014_0018
crossref_primary_10_4049_jimmunol_0803883
crossref_primary_10_1007_s12035_019_01757_9
crossref_primary_10_1182_bloodadvances_2018026450
crossref_primary_10_1038_s41590_019_0316_2
crossref_primary_10_4049_jimmunol_1200360
crossref_primary_10_1371_journal_ppat_1004873
crossref_primary_10_4049_jimmunol_1101477
crossref_primary_10_1371_journal_ppat_1002173
crossref_primary_10_1084_jem_20070104
crossref_primary_10_1016_j_smim_2019_101344
crossref_primary_10_1186_ar4544
crossref_primary_10_3389_fimmu_2024_1250818
Cites_doi 10.1146/annurev.immunol.20.100301.064842
10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8
10.4049/jimmunol.147.11.3815
10.4049/jimmunol.175.6.3569
10.1084/jem.20020732
10.4049/jimmunol.157.2.798
10.4049/jimmunol.174.12.8064
10.1086/320731
10.1016/S1074-7613(01)00227-8
10.1016/j.immuni.2005.02.008
10.4049/jimmunol.175.2.1041
10.1038/374546a0
10.1038/nri1004
10.1182/blood-2003-07-2465
10.1016/0092-8674(93)80068-P
10.1128/IAI.66.11.5157-5166.1998
10.1128/IAI.69.7.4561-4571.2001
10.1189/jlb.0602325
10.1038/nri1460
10.1038/35100529
10.1084/jem.182.1.99
10.1146/annurev.immunol.19.1.683
10.1084/jem.20041789
10.1023/A:1008942828960
10.1016/S0952-7915(02)00013-4
10.4049/jimmunol.157.5.2116
10.1007/s00335-004-2392-2
10.1073/pnas.0400983101
10.1172/JCI118290
ContentType Journal Article
Copyright Copyright © 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: Copyright © 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
H94
7X8
DOI 10.1002/eji.200636012
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1521-4141
1365-2567
EndPage 3255
ExternalDocumentID 17111348
10_1002_eji_200636012
EJI200636012
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Deutsche Forschungsgemeinschaft (DFG)
  funderid: SFB 589; SFB 621
GroupedDBID ---
.3N
.55
.GA
.GJ
.HR
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
UPT
V2E
VH1
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXSBR
X7M
XG1
XPP
XV2
Y6R
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
-~X
29I
2WC
36B
52R
52V
5HH
5LA
7T5
7TM
A01
A8Z
AAFWJ
AAMMB
ABDBF
ABXGK
ACGFO
ACGOF
ACIWK
ACMXC
ACNCT
ACUHS
ADBTR
AEFGJ
AEGXH
AFEBI
AGXDD
AIACR
AIAGR
AIDQK
AIDYY
AOIJS
BAWUL
C45
CAG
COF
D-6
D-7
DIK
DRMAN
E3Z
EAD
EAP
EAS
EBB
EBC
EBX
EMB
EMK
EPT
ESX
EX3
FD6
FIJ
FUBAC
GX1
H94
HZI
IH2
IHE
K48
KBYEO
MRMAN
MSMAN
MXMAN
OBC
OBS
P2Z
P4B
Q~Q
RPM
TR2
TUS
V8K
WH7
WIJ
WOQ
WOW
WXI
YF5
YFH
YOC
YUY
7X8
ID FETCH-LOGICAL-c3702-ce469f6abcaea24b3dc46558da5e48b1533a0d572340c088b967ef06ef33f5c93
IEDL.DBID DR2
ISSN 0014-2980
IngestDate Fri Jul 11 00:55:58 EDT 2025
Fri Jul 11 01:18:06 EDT 2025
Wed Feb 19 01:46:47 EST 2025
Tue Jul 01 00:48:37 EDT 2025
Thu Apr 24 23:00:45 EDT 2025
Wed Jan 22 16:45:18 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3702-ce469f6abcaea24b3dc46558da5e48b1533a0d572340c088b967ef06ef33f5c93
Notes The first two authors as well as the last two authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 17111348
PQID 19699743
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_68211114
proquest_miscellaneous_19699743
pubmed_primary_17111348
crossref_citationtrail_10_1002_eji_200636012
crossref_primary_10_1002_eji_200636012
wiley_primary_10_1002_eji_200636012_EJI200636012
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2006
PublicationDateYYYYMMDD 2006-12-01
PublicationDate_xml – month: 12
  year: 2006
  text: December 2006
PublicationDecade 2000
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle European Journal of Immunology
PublicationTitleAlternate Eur J Immunol
PublicationYear 2006
Publisher WILEY‐VCH Verlag
Publisher_xml – name: WILEY‐VCH Verlag
References 2004; 200
2004; 101
1995; 96
1998; 28
2001; 183
2005; 174
2005; 175
2002; 196
2004; 4
2003; 15
1999; 8
1995; 374
2003; 73
2001; 69
2005; 22
1998; 66
1991; 147
2002; 20
2004; 15
1993; 75
2001; 19
2003; 3
2001; 15
2001; 1
1996; 157
2003; 102
1995; 182
Gazzinelli R. T. (e_1_2_6_9_2) 1996; 157
Stacey K. J. (e_1_2_6_16_2) 1996; 157
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_12_2
e_1_2_6_13_2
e_1_2_6_10_2
e_1_2_6_11_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
Fiorentino D. F. (e_1_2_6_20_2) 1991; 147
Kullberg M. C. (e_1_2_6_7_2) 1998; 66
e_1_2_6_8_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_1_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
e_1_2_6_26_2
e_1_2_6_25_2
References_xml – volume: 182
  start-page: 99
  year: 1995
  end-page: 108
  article-title: Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.
  publication-title: J. Exp. Med.
– volume: 28
  start-page: 2045
  year: 1998
  end-page: 2054
  article-title: Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.
  publication-title: Eur. J. Immunol.
– volume: 374
  start-page: 546
  year: 1995
  end-page: 549
  article-title: CpG motifs in bacterial DNA trigger direct B‐cell activation.
  publication-title: Nature
– volume: 102
  start-page: 4487
  year: 2003
  end-page: 4492
  article-title: IL‐10 regulates plasmacytoid dendritic cell response to CpG‐containing immunostimulatory sequences.
  publication-title: Blood
– volume: 69
  start-page: 4561
  year: 2001
  end-page: 4571
  article-title: Endogenous interleukin‐10 is required for prevention of a hyperinflammatory intracerebral immune response in meningoencephalitis.
  publication-title: Infect. Immun.
– volume: 15
  start-page: 5
  year: 2003
  end-page: 11
  article-title: Mammalian Toll‐like receptors.
  publication-title: Curr. Opin. Immunol.
– volume: 15
  start-page: 865
  year: 2004
  end-page: 871
  article-title: Refined histopathologic scoring system improves power to detect colitis QTL in mice.
  publication-title: Mamm. Genome
– volume: 175
  start-page: 3569
  year: 2005
  end-page: 3576
  article-title: Differences in macrophage activation by bacterial DNA and CpG‐containing oligonucleotides.
  publication-title: J. Immunol.
– volume: 66
  start-page: 5157
  year: 1998
  end-page: 5166
  article-title: triggers colitis in specific‐pathogen‐free interleukin‐10 (IL‐10)‐deficient mice through an IL‐12‐ and gamma interferon‐dependent mechanism.
  publication-title: Infect. Immun.
– volume: 157
  start-page: 798
  year: 1996
  end-page: 805
  article-title: In the absence of endogenous IL‐10, mice acutely infected with succumb to a lethal immune response dependent on CD4 T cells and accompanied by overproduction of IL‐12, IFN‐gamma and TNF‐alpha.
  publication-title: J. Immunol.
– volume: 96
  start-page: 2339
  year: 1995
  end-page: 2347
  article-title: Interleukin‐10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.
  publication-title: J. Clin. Invest.
– volume: 22
  start-page: 467
  year: 2005
  end-page: 477
  article-title: Upon TLR9 signaling, CD5 B cells control the IL‐12‐dependent Th1‐priming capacity of neonatal DCs.
  publication-title: Immunity
– volume: 157
  start-page: 2116
  year: 1996
  end-page: 2122
  article-title: Macrophages ingest and are activated by bacterial DNA.
  publication-title: J. Immunol.
– volume: 175
  start-page: 1041
  year: 2005
  end-page: 1046
  article-title: Identification of a macrophage‐specific chromatin signature in the IL‐10 locus.
  publication-title: J. Immunol.
– volume: 3
  start-page: 169
  year: 2003
  end-page: 76
  article-title: Innate immune sensing and its roots: the story of endotoxin.
  publication-title: Nat. Rev. Immunol.
– volume: 15
  start-page: 763
  year: 2001
  end-page: 774
  article-title: A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.
  publication-title: Immunity
– volume: 200
  start-page: 1289
  year: 2004
  end-page: 1297
  article-title: T cell‐specific inactivation of the interleukin‐10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.
  publication-title: J. Exp. Med.
– volume: 1
  start-page: 135
  year: 2001
  end-page: 145
  article-title: Toll‐like receptors and innate immunity.
  publication-title: Nat. Rev. Immunol.
– volume: 75
  start-page: 263
  year: 1993
  end-page: 274
  article-title: Interleukin‐10‐deficient mice develop chronic enterocolitis.
  publication-title: Cell
– volume: 8
  start-page: 265
  year: 1999
  end-page: 277
  article-title: Conditional gene targeting in macrophages and granulocytes using LysM‐cre mice.
  publication-title: Transgenic Research
– volume: 73
  start-page: 209
  year: 2003
  end-page: 212
  article-title: The many faces of macrophage activation.
  publication-title: J. Leukoc. Biol.
– volume: 174
  start-page: 8064
  year: 2005
  end-page: 8071
  article-title: Involvement of SHIP in TLR2‐induced neutrophil activation and acute lung injury.
  publication-title: J. Immunol.
– volume: 183
  start-page: 1794
  year: 2001
  end-page: 1800
  article-title: Relative contribution of interferon‐gamma and interleukin‐10 to resistance to murine African trypanosomosis.
  publication-title: J. Infect. Dis.
– volume: 147
  start-page: 3815
  year: 1991
  end-page: 3822
  article-title: IL‐10 inhibits cytokine production by activated macrophages.
  publication-title: J. Immunol.
– volume: 101
  start-page: 4560
  year: 2004
  end-page: 4565
  article-title: Human IL‐23‐producing type 1 macrophages promote but IL‐10‐producing type 2 macrophages subvert immunity to (myco)bacteria.
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 20
  start-page: 709
  year: 2002
  end-page: 760
  article-title: CpG motifs in bacterial DNA and their immune effects.
  publication-title: Annu. Rev. Immunol.
– volume: 19
  start-page: 683
  year: 2001
  end-page: 765
  article-title: Interleukin‐10 and the interleukin‐10 receptor.
  publication-title: Annu. Rev. Immunol.
– volume: 196
  start-page: 541
  year: 2002
  end-page: 549
  article-title: Reversal of tumor‐induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti‐interleukin 10 receptor antibody.
  publication-title: J. Exp. Med.
– volume: 4
  start-page: 787
  year: 2004
  end-page: 799
  article-title: Mast‐cell responses to pathogens.
  publication-title: Nat. Rev. Immunol.
– ident: e_1_2_6_4_2
  doi: 10.1146/annurev.immunol.20.100301.064842
– ident: e_1_2_6_25_2
  doi: 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8
– volume: 147
  start-page: 3815
  year: 1991
  ident: e_1_2_6_20_2
  article-title: IL‐10 inhibits cytokine production by activated macrophages.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.147.11.3815
– ident: e_1_2_6_17_2
  doi: 10.4049/jimmunol.175.6.3569
– ident: e_1_2_6_19_2
  doi: 10.1084/jem.20020732
– volume: 157
  start-page: 798
  year: 1996
  ident: e_1_2_6_9_2
  article-title: In the absence of endogenous IL‐10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL‐12, IFN‐gamma and TNF‐alpha.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.157.2.798
– ident: e_1_2_6_24_2
  doi: 10.4049/jimmunol.174.12.8064
– ident: e_1_2_6_10_2
  doi: 10.1086/320731
– ident: e_1_2_6_29_2
  doi: 10.1016/S1074-7613(01)00227-8
– ident: e_1_2_6_27_2
  doi: 10.1016/j.immuni.2005.02.008
– ident: e_1_2_6_22_2
  doi: 10.4049/jimmunol.175.2.1041
– ident: e_1_2_6_28_2
  doi: 10.1038/374546a0
– ident: e_1_2_6_3_2
  doi: 10.1038/nri1004
– ident: e_1_2_6_18_2
  doi: 10.1182/blood-2003-07-2465
– ident: e_1_2_6_6_2
  doi: 10.1016/0092-8674(93)80068-P
– volume: 66
  start-page: 5157
  year: 1998
  ident: e_1_2_6_7_2
  article-title: Helicobacter hepaticus triggers colitis in specific‐pathogen‐free interleukin‐10 (IL‐10)‐deficient mice through an IL‐12‐ and gamma interferon‐dependent mechanism.
  publication-title: Infect. Immun.
  doi: 10.1128/IAI.66.11.5157-5166.1998
– ident: e_1_2_6_8_2
  doi: 10.1128/IAI.69.7.4561-4571.2001
– ident: e_1_2_6_23_2
  doi: 10.1189/jlb.0602325
– ident: e_1_2_6_26_2
  doi: 10.1038/nri1460
– ident: e_1_2_6_1_2
  doi: 10.1038/35100529
– ident: e_1_2_6_12_2
  doi: 10.1084/jem.182.1.99
– ident: e_1_2_6_5_2
  doi: 10.1146/annurev.immunol.19.1.683
– ident: e_1_2_6_13_2
  doi: 10.1084/jem.20041789
– ident: e_1_2_6_15_2
  doi: 10.1023/A:1008942828960
– ident: e_1_2_6_2_2
  doi: 10.1016/S0952-7915(02)00013-4
– volume: 157
  start-page: 2116
  year: 1996
  ident: e_1_2_6_16_2
  article-title: Macrophages ingest and are activated by bacterial DNA.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.157.5.2116
– ident: e_1_2_6_14_2
  doi: 10.1007/s00335-004-2392-2
– ident: e_1_2_6_21_2
  doi: 10.1073/pnas.0400983101
– ident: e_1_2_6_11_2
  doi: 10.1172/JCI118290
SSID ssj0009659
ssj0013055
Score 2.2200522
Snippet Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective...
Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3248
SubjectTerms Adjuvants, Immunologic - administration & dosage
Animals
Cells, Cultured
CpG Islands - immunology
Cytokines
Inflammation
Inflammation Mediators - metabolism
Inflammation Mediators - physiology
Interleukin-10 - deficiency
Interleukin-10 - genetics
Interleukin-10 - physiology
Knock‐out mice
Lipopolysaccharides - administration & dosage
Lipopolysaccharides - immunology
Macrophages
Macrophages - immunology
Macrophages - metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Neutrophils
Neutrophils - immunology
Neutrophils - metabolism
Oligodeoxyribonucleotides - administration & dosage
Oligodeoxyribonucleotides - immunology
Title Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.200636012
https://www.ncbi.nlm.nih.gov/pubmed/17111348
https://www.proquest.com/docview/19699743
https://www.proquest.com/docview/68211114
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTxQxFG8IicSLAn6wgtiD8eSwnbbzdSQIAhFiVBJuYz_DwjJDdmdM4MTNq3-jf4mv7eyui8HEeJz2NdPpvM--9vcQek0TmlkuVWQ1hQAlZkkkHeIQWEJqMy0K7auWHB2n-yf88DQ57eqcurswAR9iuuHmJMPrayfgQo77M9BQcz7wmQMGIYXTwe68lnOKPs3goxxYXtDEPKJFTjqMTRjfnxs9b5P-cDTn_VZvePYeo6-TKYfzJhdbbSO31M0dNMf_-KZl9KhzSvF24KIVtGCqVfQglKm8XkVLR10C_gn67ncQh6a9GFQ_b3_EBGtg4W9GY3dPBV8KVxHsDHTUGItK9-sRrkzbuLbBcIxHofA9dILbiYG3gR0vfZofuvxZXYObGn_4-BnLtsFV3XjC3_t2rt7jd8fbT9HJ3u6Xnf2oq-UQKZaB0lUG4nCbCqmEEZRLppVDbsu1SAzPpfM6BdFJRhknCjSfLNLMWJIay5hNVMGeocWqrswawrnREOQpIS1XPFZEZAU1xBKRiziV3PbQ28nfLFUHdO7qbQzLANFMS1jmcrrMPfRmSn4VED7uI3w1YY0SZNAlVkRl6nZcOoghiMvY_RRpTp1t4j30PPDU7FUZtDOe9xDxnPH3OZS7hwfThxf_PmQdPaRd5SUSb6DFZtSal-BVNXLTi84vr8kaMQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Lb9MwGLfQ0GAXGANGec0HxImsju28jtMedKOtEGzSbpGfrFuXTG2CBCduXPkb-Uv47KTtChoS4hj7c-I439Of8_sQekUjmlguVWA1hQAlZFEgHeIQWEJqEy0y7auWDIZx74QfnUan1_7ib_Ah5htuTjK8vnYC7jakuwvUUHM-8qkDBjEFKOHbrqq3Q8_f-7AAkHJweY0u5gHNUtKibMINukvDl63SH67msufqTc_BfSRmk25OnFxs15XcVl9_w3P8n7daR_davxTvNIz0AN0yxQZabSpVftlAdwZtDv4h-u43EcemvhgVP7_9CAnWwMWfjcbuVxV8KVxRsDNQU1MsCt0tJ7gwdeXaRuMpnphPrmAYdILniYG9gSMvfaYfuvxxXYOrEvfff8SyrnBRVp7wet_u1Vu8N9x5hE4O9o93e0FbziFQLAG9qwyE4jYWUgkjKJdMKwfelmoRGZ5K53gKoqOEMk4UKD-ZxYmxJDaWMRupjD1GK0VZmCcIp0ZDnKeEtFzxUBGRZNQQS0Qqwlhy20FvZp8zVy3WuSu5Mc4blGaawzLn82XuoNdz8qsG5OMmwq0Zb-Qghi63IgpT1tPcoQxBaMZupohT6swT76DNhqkWj0qgnfG0g4hnjb_PId8_OpxfPP33IVvobu940M_7h8N3z9AabQsxkfA5WqkmtXkBTlYlX3o5-gVINh5N
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9MwHLfQEBMXHgNGgTEfECeyOrbzOk7rugdbNQGTdgt-irIuqdoEiZ1223WfkU_C307aUtCQEMf4kTjO_2k7vx9Cb2hEE8ulCqymkKCELAqkQxwCT0htokWmPWvJ8SDeP-WHZ9FZy3Pq_oVp8CHmC25OM7y9dgo-1ra7AA01X4d-54BBSgE2-C6PSea4G3ofFvhRDi2vMcU8oFlKWpBNuEF3qfuyU_oj0lwOXL3n6T9En2djbg6cnG_VldxSl7_BOf7HSz1CD9qoFG83YvQY3THFGrrX8FR-X0Orx-0O_BN07ZcQR6Y-HxY_rm5CgjXI8DejsftRBV8IRwn2BYzUFItCd8sJLkxdubLhaIonDfM9VELciUG4QR4v_D4_VPnDugZXJT46-YhlXeGirHzDX-t2xnu4N9h-ik77u5929oOWzCFQLAGrqwwk4jYWUgkjKJdMKwfdlmoRGZ5KF3YKoqOEMk4UmD6ZxYmxJDaWMRupjD1DK0VZmOcIp0ZDlqeEtFzxUBGRZNQQS0Qqwlhy20HvZl8zVy3SuSPcGOUNRjPNYZrz-TR30Nt583ED8XFbw82ZaOSghG5nRRSmrKe5wxiCxIzd3iJOqXNOvIPWG5laPCqBcsbTDiJeMv4-hnz38GB-8eLfu2yi1ZNePz86GLx_ie7TloWJhK_QSjWpzQZEWJV87bXoJ9InHPw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-10+derived+from+macrophages+and%2For+neutrophils+regulates+the+inflammatory+response+to+LPS+but+not+the+response+to+CpG+DNA&rft.jtitle=European+journal+of+immunology&rft.au=Siewe%2C+Lisa&rft.au=Bollati-Fogolin%2C+Mariela&rft.au=Wickenhauser%2C+Claudia&rft.au=Krieg%2C+Thomas&rft.date=2006-12-01&rft.issn=0014-2980&rft.volume=36&rft.issue=12&rft.spage=3248&rft_id=info:doi/10.1002%2Feji.200636012&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon